Claim deep dive·Emerging evidence·Updated July 13, 2026
Evidence review: Vitamin K2 may reduce arterial calcification
Mechanism (activation of matrix Gla protein) is well-established. Clinical evidence for reversing or slowing arterial calcification in humans is suggestive but not yet conclusive.
The bottom line.
The strongest studies.
Sorted by study tier (meta-analyses first, then RCTs, then reviews) and recency. Every entry links to PubMed by PMID, and every citation on this page points here.
Randomized controlled trials
3- 1No Detectable Coagulation Activation After Vitamin K (MK-7) Supplementation in Patients on Dialysis With Functional Vitamin K Deficiency: A One-Year Randomized, Placebo-Controlled StudySource linkedPMIDBladbjerg EM, Levy-Schousboe K, Frimodt-Møller M et al. · Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2024
- 2Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled TrialSource linkedPMIDNaiyarakseree N, Phannajit J, Naiyarakseree W et al. · Nutrients · 2023
- 3Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding studySource linkedPMIDCaluwé R, Vandecasteele S, Van Vlem B et al. · Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2014
Reviews & position papers
1- 4The Dual Role of Vitamin K2 in 'Bone-Vascular Crosstalk': Opposite Effects on Bone Loss and Vascular CalcificationSource linkedPMIDMandatori D et al. · Nutrients · 2021
Vitamin K2 deficiency may be responsible for the 'calcium paradox', low calcium in bone and accumulation in vessel walls; K2 activates both osteocalcin and MGP
What pushes back.
Caveats, null findings, and methodological limits that hold the tier where it is.
What the evidence supports.
What we recommend
180 mcg/day MK-7 alongside vitamin D is reasonable if you supplement higher-dose D3, but do not expect this to reverse existing coronary calcification. 3,1
Tier criteria: /methodology/evidence-tiers. Sourcing standards: /methodology/interactions.
Common questions.
Quick answers drawn from the verdict, evidence, and recommendation above.
Does the evidence support the claim that vitamin k2 may reduce arterial calcification?
Mechanism (activation of matrix Gla protein) is well-established. Clinical evidence for reversing or slowing arterial calcification in humans is suggestive but not yet conclusive.
How strong is the evidence behind Vitamin K2 and Vitamin K2 MK-4 for this claim?
NutriStack rates this as Emerging evidence, meaning early RCT signal, mechanistic data, or limited human evidence. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
What contrary evidence or caveats apply?
Most calcification data comes from rodent and observational studies. Hard cardiovascular outcomes are not yet established.
What does NutriStack recommend?
180 mcg/day MK-7 alongside vitamin D is reasonable if you supplement higher-dose D3, but do not expect this to reverse existing coronary calcification.
Selected claims, opened up
This is how NutriStack presents an evidence review.
Each published claim review shows its verdict, attached studies, contrary evidence, dose context, and limits. Coverage is selective rather than a claim that every database assertion has received the same review.